Quest for High-Performance, Cost-effective Products Defines Western European Advanced Wound Management Market, Says Frost & Sullivan PR Newswire LONDON, June 20, 2012 - Quest Attracts Intensifying Competition while Simultaneously Threatening to Derail Market by Skewing Product Pricing LONDON, June 20, 2012 /PRNewswire/ -- An ageing population and the increasing incidence of lifestyle diseases, such as obesity and diabetes, are being paralleled by a steady stream of technologically advanced, high- performance, cost-effective advanced wound management products. Studies touting the long-term cost efficiency of using such products over traditional equivalents will provide a further fillip to the advanced wound management market. New analysis from Frost & Sullivan (http://www.medicaldevices.frost.com), Less Pain, More Gain—Analysis of the Advanced Wound Management Market, finds that the market in Western Europe generated $ 1,508.4 million in 2010 and estimates this to reach $ 2491.2 million in 2017. The research covers moist wound dressings, antimicrobial dressings, active therapies and negative pressure wound therapy (NPWT). "Advanced wound management usually comprises treatment of chronic wounds in elderly patients," notes Frost & Sullivan Research Analyst Brahadeesh Chandrasekaran. "As the incidence of chronic wounds rises, it is set to trigger demand for advanced wound management products.